Huppes W, De Geus B, Zurcher C, Van Bekkum D W
Institute of Radiobiology, Erasmus University, Rotterdam, The Netherlands.
Eur J Immunol. 1992 Jan;22(1):197-206. doi: 10.1002/eji.1830220129.
Recent reports of persistent engraftment of human lymphocytes and myeloid cells in hereditary immunodeficient severe combined immunodeficient mice (SCID) and beige athymic nude X-linked immunodeficiency (Bg/Nu/XID) mice have raised the question of why attempts to graft human cells into artificially immunosuppressed normal mice have failed so far. In the present study we provide evidence that this difference is due to the absence of natural antibodies in the mutant mice. We demonstrate that human PBL can be grafted in normal mice immunosuppressed by heavy doses of total body irradiation, provided the transplant is performed when the recipients lack natural antibodies in their serum, e.g. as in newborn normal mice, in mice treated with anti-mouse IgM antibody from birth, and in 3-week-old B cell-deficient CBA/N mice. In all cases, large numbers of human PBL were required. Under these conditions an acute and fatal graft vs. host disease (GVHD) developed in the recipients, regardless of whether these were artificially immunosuppressed or hereditary immunodeficient. The clinical manifestations and the histopathology of this xenogeneic acute GVHD are quite different from those of allogeneic GVHD. The former is primarily confined to the hematolymphoid tissues and locations close to accumulations of proliferating lymphoblasts, such as the peritoneal cavity in case of i.p. transplantation. The discordant xenogeneic GVHD is induced by human T lymphocytes and can be abrogated by treatment with anti-human T cell serum.
最近有报道称,人类淋巴细胞和髓样细胞能在遗传性免疫缺陷的重症联合免疫缺陷小鼠(SCID)以及米色无胸腺裸X连锁免疫缺陷小鼠(Bg/Nu/XID)中长期植入,这引发了一个问题:为何将人类细胞移植到人工免疫抑制的正常小鼠中的尝试至今都失败了。在本研究中,我们提供了证据表明这种差异是由于突变小鼠中缺乏天然抗体所致。我们证明,在受者血清中缺乏天然抗体时,例如新生正常小鼠、从出生就用抗小鼠IgM抗体处理的小鼠以及3周龄B细胞缺陷的CBA/N小鼠,通过大剂量全身照射免疫抑制的正常小鼠能够植入人类外周血淋巴细胞(PBL)。在所有情况下,都需要大量的人类PBL。在这些条件下,无论受者是人工免疫抑制的还是遗传性免疫缺陷的,都会在受者中发生急性致命的移植物抗宿主病(GVHD)。这种异种急性GVHD的临床表现和组织病理学与同种异体GVHD有很大不同。前者主要局限于血液淋巴组织以及靠近增殖性淋巴母细胞聚集的部位,例如腹腔内移植时的腹腔。这种不一致的异种GVHD是由人类T淋巴细胞诱导的,并且可以通过用抗人类T细胞血清治疗来消除。